_id
691b136e3c536f8df2318af4
Ticker
BLC.PA
Name
Bastide Le Confort Médical SA
Exchange
PA
Address
Euro 2000 Centre, Caissargues, France, 30132
Country
France
Sector
Healthcare
Industry
Medical Distribution
Currency
EUR
Website
https://www.bastideleconfortmedical.com
Description
Bastide Le Confort Médical SA, together with its subsidiaries, engages in the sale and rental of medical equipment in France, the United Kingdom, Belgium, Spain, Canada, the Netherlands, and Italy. It operates in six segments: Respiratory Assistance, Home Care, Healthcare Facilities, Nutrition/Infusion/Diabetes, Stoma Therapy/Urology/Wound Care, and E-commerce. The company offers reclining chairs, lift chairs, and accessories and tables for armchairs; incontinence products, including sample wait, slip absorbent, adult complete change, incontinence diapers, and onesies, anatomical, male urinary, and right-hand protections, incontinence panties and swimsuits, disposable bed pads, support briefs, slips filets, feminine hygiene products, hygiene incontinence, and washable and reusable briefs and panties for urinary incontinence; and mobility products, such as walkers and rollators, walking sticks, electric scooters, and manual and electric wheelchairs. It also provides medical equipment comprising heating products, bathroom medical equipment, medical measuring device, medical pillow and cushion, technical support, electrostimulation and circulatory stimulators, pressotherapy device, pedal exerciser for seniors, seniors' telephone, bedside tables, medicalized room, sleep apnea device, natural food supplement, thermal compresses, pedicure and foot care, comfort shoes, first aid products, and wellness and health. In addition, the company offers professional equipment, which includes consumable for healthcare professionals, hygiene and disinfection, care and dressings, diagnosis and self-checking, and other medical equipment; and rental and services for medical bed, wheelchair, air mattress, patient lift, and verticalizer. It exports its products. The company was incorporated in 1976 and is headquartered in Caissargues, France. Bastide Le Confort Médical SA operates as a subsidiary of Societe d'Investissement Bastide SAS.
Last Close
24.4
Volume
1803
Current Price
24.4
Change
0
Last Updated
2025-12-30T12:45:39.041Z
Image
https://logo.clearbit.com/www.bastideleconfortmedical.com
Ipo Date
-
Market Cap
178362096
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Rating
4.33
Strong Buy
1
Buy
2
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-06-30
Revenue
215651000
Cost Of Revenue
195005000
Gross Profit
20646000
Operating Expenses
1452000
Operating Income
19194000
Interest Expense
15300000
Pretax Income
2471000
Net Income
-87000
Eps
-0.011735080160713946
Dividends Per Share
-
Shares Outstanding
7309922
Income Tax Expense
964000
EBITDA
43766000
Operating Margin
8.900491998645961
Total Other Income Expense Net
-16723000
Cash
25490000
Short Term Investments
-
Receivables
98924000
Inventories
39956000
Total Current Assets
276587000
Property Plant Equipment
183546000
Total Assets
661028000
Payables
74259000
Short Term Debt
29632000
Long Term Debt
343307000
Total Liabilities
589730000
Equity
72132000
Bs_currency_symbol
EUR
Depreciation
26024000
Change In Working Capital
392000
Cash From Operations
34124000
Capital Expenditures
22469000
Cash From Investing
-20092000
Cash From Financing
-10187000
Net Change In Cash
-5815000
Cf_currency_symbol
-
PE
64.2105
PB
2.507812393944435
ROE
-0.12061221094659791
ROA
-0.013161318431291867
FCF
11655000
Fcf Percent
0.05404565710337536
Piotroski FScore
2
Health Score
21
Deep Value Investing Score
4.5
Defensive Investing Score
5.5
Dividend Investing Score
3
Economic Moat Investing Score
5.8
Garp Investing Score
2.5
Growth Investing Score
3
Momentum Investing Score
6
Net Net Investing Score
2.5
Quality Investing Score
3.5
Value Investing Score
3.5
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
215651000
Quarters > 0 > income Statement > cost Of Revenue
195005000
Quarters > 0 > income Statement > gross Profit
20646000
Quarters > 0 > income Statement > operating Expenses
1452000
Quarters > 0 > income Statement > operating Income
19194000
Quarters > 0 > income Statement > interest Expense
15300000
Quarters > 0 > income Statement > pretax Income
2471000
Quarters > 0 > income Statement > net Income
-87000
Quarters > 0 > income Statement > eps
-0.011735080160713946
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
7413669
Quarters > 0 > income Statement > income Tax Expense
964000
Quarters > 0 > income Statement > EBITDA
43766000
Quarters > 0 > income Statement > operating Margin
8.900491998645961
Quarters > 0 > income Statement > total Other Income Expense Net
-16723000
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
25490000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
98924000
Quarters > 0 > balance Sheet > inventories
39956000
Quarters > 0 > balance Sheet > total Current Assets
276587000
Quarters > 0 > balance Sheet > property Plant Equipment
183546000
Quarters > 0 > balance Sheet > total Assets
661028000
Quarters > 0 > balance Sheet > payables
74259000
Quarters > 0 > balance Sheet > short Term Debt
29632000
Quarters > 0 > balance Sheet > long Term Debt
343307000
Quarters > 0 > balance Sheet > total Liabilities
589730000
Quarters > 0 > balance Sheet > equity
72132000
Quarters > 0 > balance Sheet > currency_symbol
EUR
Quarters > 0 > cash Flow > net Income
2031000
Quarters > 0 > cash Flow > depreciation
26024000
Quarters > 0 > cash Flow > change In Working Capital
392000
Quarters > 0 > cash Flow > cash From Operations
34124000
Quarters > 0 > cash Flow > capital Expenditures
22469000
Quarters > 0 > cash Flow > cash From Investing
-20092000
Quarters > 0 > cash Flow > cash From Financing
-10187000
Quarters > 0 > cash Flow > net Change In Cash
-5815000
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-0.011735080160713946
Quarters > 0 > ratios > PB
2.507812393944435
Quarters > 0 > ratios > ROE
-0.12061221094659791
Quarters > 0 > ratios > ROA
-0.013161318431291867
Quarters > 0 > ratios > FCF
11655000
Quarters > 0 > ratios > Piotroski FScore
2
Quarters > 0 > ratios > fcf Percent
0.05404565710337536
Quarters > 0 > health Score
21
Quarters > 1 > quarter
2024-12-31
Quarters > 1 > income Statement > revenue
275529000
Quarters > 1 > income Statement > cost Of Revenue
248032000
Quarters > 1 > income Statement > gross Profit
27497000
Quarters > 1 > income Statement > operating Expenses
2467000
Quarters > 1 > income Statement > operating Income
25030000
Quarters > 1 > income Statement > interest Expense
16574000
Quarters > 1 > income Statement > pretax Income
8069000
Quarters > 1 > income Statement > net Income
615000
Quarters > 1 > income Statement > eps
0.07791976772560687
Quarters > 1 > income Statement > dividends Per Share
1100000
Quarters > 1 > income Statement > shares Outstanding
7892734
Quarters > 1 > income Statement > income Tax Expense
5528000
Quarters > 1 > income Statement > EBITDA
57651000
Quarters > 1 > income Statement > operating Margin
9.084343208881823
Quarters > 1 > income Statement > total Other Income Expense Net
-16961000
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
31305000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
119141000
Quarters > 1 > balance Sheet > inventories
62793000
Quarters > 1 > balance Sheet > total Current Assets
231763000
Quarters > 1 > balance Sheet > property Plant Equipment
217854000
Quarters > 1 > balance Sheet > total Assets
675968000
Quarters > 1 > balance Sheet > payables
89911000
Quarters > 1 > balance Sheet > short Term Debt
44199000
Quarters > 1 > balance Sheet > long Term Debt
349267000
Quarters > 1 > balance Sheet > total Liabilities
598325000
Quarters > 1 > balance Sheet > equity
76078000
Quarters > 1 > balance Sheet > currency_symbol
EUR
Quarters > 1 > cash Flow > net Income
985000
Quarters > 1 > cash Flow > depreciation
33007000
Quarters > 1 > cash Flow > change In Working Capital
4763000
Quarters > 1 > cash Flow > cash From Operations
37748000
Quarters > 1 > cash Flow > capital Expenditures
37611000
Quarters > 1 > cash Flow > cash From Investing
-36347000
Quarters > 1 > cash Flow > cash From Financing
5852000
Quarters > 1 > cash Flow > net Change In Cash
7689000
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
0.07791976772560687
Quarters > 1 > ratios > PB
2.5313850206367148
Quarters > 1 > ratios > ROE
0.8083808722626777
Quarters > 1 > ratios > ROA
0.09098063813671653
Quarters > 1 > ratios > FCF
137000
Quarters > 1 > ratios > Piotroski FScore
4
Quarters > 1 > ratios > fcf Percent
0.0004972253374417938
Quarters > 1 > health Score
32
Quarters > 2 > quarter
2024-06-30
Quarters > 2 > income Statement > revenue
264731000
Quarters > 2 > income Statement > cost Of Revenue
240637000
Quarters > 2 > income Statement > gross Profit
24094000
Quarters > 2 > income Statement > operating Expenses
1923000
Quarters > 2 > income Statement > operating Income
22171000
Quarters > 2 > income Statement > interest Expense
17544000
Quarters > 2 > income Statement > pretax Income
7779000
Quarters > 2 > income Statement > net Income
1093000
Quarters > 2 > income Statement > eps
0.1484000022266789
Quarters > 2 > income Statement > dividends Per Share
1628000
Quarters > 2 > income Statement > shares Outstanding
7365229
Quarters > 2 > income Statement > income Tax Expense
1902000
Quarters > 2 > income Statement > EBITDA
57087000
Quarters > 2 > income Statement > operating Margin
8.374916424597044
Quarters > 2 > income Statement > total Other Income Expense Net
-14392000
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
23616000
Quarters > 2 > balance Sheet > short Term Investments
3915000
Quarters > 2 > balance Sheet > receivables
107234000
Quarters > 2 > balance Sheet > inventories
59067000
Quarters > 2 > balance Sheet > total Current Assets
208922000
Quarters > 2 > balance Sheet > property Plant Equipment
208396000
Quarters > 2 > balance Sheet > total Assets
647067000
Quarters > 2 > balance Sheet > payables
77021000
Quarters > 2 > balance Sheet > short Term Debt
65921000
Quarters > 2 > balance Sheet > long Term Debt
291048000
Quarters > 2 > balance Sheet > total Liabilities
566342000
Quarters > 2 > balance Sheet > equity
79772000
Quarters > 2 > balance Sheet > currency_symbol
EUR
Quarters > 2 > cash Flow > net Income
8179000
Quarters > 2 > cash Flow > depreciation
31766000
Quarters > 2 > cash Flow > change In Working Capital
6664000
Quarters > 2 > cash Flow > cash From Operations
44281000
Quarters > 2 > cash Flow > capital Expenditures
29435000
Quarters > 2 > cash Flow > cash From Investing
-30037000
Quarters > 2 > cash Flow > cash From Financing
-26573000
Quarters > 2 > cash Flow > net Change In Cash
-12150000
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
0.1484000022266789
Quarters > 2 > ratios > PB
2.252815368801083
Quarters > 2 > ratios > ROE
1.370154941583513
Quarters > 2 > ratios > ROA
0.1689160473335837
Quarters > 2 > ratios > FCF
14846000
Quarters > 2 > ratios > Piotroski FScore
4
Quarters > 2 > ratios > fcf Percent
0.056079567561033654
Quarters > 2 > health Score
38
Quarters > 3 > quarter
2023-12-31
Quarters > 3 > income Statement > revenue
265024000
Quarters > 3 > income Statement > cost Of Revenue
87027000
Quarters > 3 > income Statement > gross Profit
177997000
Quarters > 3 > income Statement > operating Expenses
157348000
Quarters > 3 > income Statement > operating Income
20649000
Quarters > 3 > income Statement > interest Expense
12947000
Quarters > 3 > income Statement > pretax Income
8723000
Quarters > 3 > income Statement > net Income
-1993000
Quarters > 3 > income Statement > eps
-0.26903507526232606
Quarters > 3 > income Statement > dividends Per Share
1996000
Quarters > 3 > income Statement > shares Outstanding
7407956
Quarters > 3 > income Statement > income Tax Expense
5113000
Quarters > 3 > income Statement > EBITDA
41411000
Quarters > 3 > income Statement > operating Margin
7.791369838203332
Quarters > 3 > income Statement > total Other Income Expense Net
-11926000
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
35766000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
101394000
Quarters > 3 > balance Sheet > inventories
48267000
Quarters > 3 > balance Sheet > total Current Assets
208898000
Quarters > 3 > balance Sheet > property Plant Equipment
213018000
Quarters > 3 > balance Sheet > total Assets
659363000
Quarters > 3 > balance Sheet > payables
73042000
Quarters > 3 > balance Sheet > short Term Debt
65244000
Quarters > 3 > balance Sheet > long Term Debt
312362000
Quarters > 3 > balance Sheet > total Liabilities
575981000
Quarters > 3 > balance Sheet > equity
80449000
Quarters > 3 > balance Sheet > currency_symbol
EUR
Quarters > 3 > cash Flow > net Income
-799000
Quarters > 3 > cash Flow > depreciation
31616000
Quarters > 3 > cash Flow > change In Working Capital
-10434000
Quarters > 3 > cash Flow > cash From Operations
34270000
Quarters > 3 > cash Flow > capital Expenditures
25960000
Quarters > 3 > cash Flow > cash From Investing
-13626000
Quarters > 3 > cash Flow > cash From Financing
-21534000
Quarters > 3 > cash Flow > net Change In Cash
-940000
Quarters > 3 > cash Flow > currency_symbol
-
Quarters > 3 > ratios > PE
-0.26903507526232606
Quarters > 3 > ratios > PB
2.246816323385002
Quarters > 3 > ratios > ROE
-2.4773458961578143
Quarters > 3 > ratios > ROA
-0.30226142504204817
Quarters > 3 > ratios > FCF
8310000
Quarters > 3 > ratios > Piotroski FScore
2
Quarters > 3 > ratios > fcf Percent
0.03135565080898334
Quarters > 3 > health Score
19
Annuals > 0 > quarter
2025-06-30
Annuals > 0 > income Statement > revenue
491180000
Annuals > 0 > income Statement > cost Of Revenue
158183000
Annuals > 0 > income Statement > gross Profit
332997000
Annuals > 0 > income Statement > operating Expenses
293830000
Annuals > 0 > income Statement > operating Income
39167000
Annuals > 0 > income Statement > interest Expense
30844000
Annuals > 0 > income Statement > pretax Income
10540000
Annuals > 0 > income Statement > net Income
528000
Annuals > 0 > income Statement > eps
0.06651805089512762
Annuals > 0 > income Statement > dividends Per Share
569000
Annuals > 0 > income Statement > shares Outstanding
7937695
Annuals > 0 > income Statement > income Tax Expense
6492000
Annuals > 0 > income Statement > EBITDA
102027000
Annuals > 0 > income Statement > operating Margin
7.974062461826621
Annuals > 0 > income Statement > total Other Income Expense Net
-28627000
Annuals > 0 > income Statement > currency_symbol
EUR
Annuals > 0 > balance Sheet > cash
25490000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
98924000
Annuals > 0 > balance Sheet > inventories
39956000
Annuals > 0 > balance Sheet > total Current Assets
276587000
Annuals > 0 > balance Sheet > property Plant Equipment
183546000
Annuals > 0 > balance Sheet > total Assets
661028000
Annuals > 0 > balance Sheet > payables
74259000
Annuals > 0 > balance Sheet > short Term Debt
29632000
Annuals > 0 > balance Sheet > long Term Debt
343307000
Annuals > 0 > balance Sheet > total Liabilities
589730000
Annuals > 0 > balance Sheet > equity
72132000
Annuals > 0 > balance Sheet > currency_symbol
EUR
Annuals > 0 > cash Flow > net Income
1560000
Annuals > 0 > cash Flow > depreciation
60643000
Annuals > 0 > cash Flow > change In Working Capital
5155000
Annuals > 0 > cash Flow > cash From Operations
71872000
Annuals > 0 > cash Flow > capital Expenditures
60080000
Annuals > 0 > cash Flow > cash From Investing
-56439000
Annuals > 0 > cash Flow > cash From Financing
-4335000
Annuals > 0 > cash Flow > net Change In Cash
1078000
Annuals > 0 > cash Flow > currency_symbol
EUR
Annuals > 0 > ratios > PE
0.06651805089512762
Annuals > 0 > ratios > PB
2.701580605695115
Annuals > 0 > ratios > ROE
0.7319913491931459
Annuals > 0 > ratios > ROA
0.07987558772094375
Annuals > 0 > ratios > FCF
11792000
Annuals > 0 > ratios > Piotroski FScore
4
Annuals > 0 > ratios > fcf Percent
0.02400749216173297
Annuals > 0 > health Score
34
Annuals > 1 > quarter
2024-06-30
Annuals > 1 > income Statement > revenue
529755000
Annuals > 1 > income Statement > cost Of Revenue
175318000
Annuals > 1 > income Statement > gross Profit
354437000
Annuals > 1 > income Statement > operating Expenses
315517000
Annuals > 1 > income Statement > operating Income
38920000
Annuals > 1 > income Statement > interest Expense
27369000
Annuals > 1 > income Statement > pretax Income
16502000
Annuals > 1 > income Statement > net Income
-900000
Annuals > 1 > income Statement > eps
-0.12063615465555026
Annuals > 1 > income Statement > dividends Per Share
1628000
Annuals > 1 > income Statement > shares Outstanding
7460450
Annuals > 1 > income Statement > income Tax Expense
7015000
Annuals > 1 > income Statement > EBITDA
107202000
Annuals > 1 > income Statement > operating Margin
7.346792385159177
Annuals > 1 > income Statement > total Other Income Expense Net
-22418000
Annuals > 1 > income Statement > currency_symbol
EUR
Annuals > 1 > balance Sheet > cash
23616000
Annuals > 1 > balance Sheet > short Term Investments
3915000
Annuals > 1 > balance Sheet > receivables
107234000
Annuals > 1 > balance Sheet > inventories
59067000
Annuals > 1 > balance Sheet > total Current Assets
208922000
Annuals > 1 > balance Sheet > property Plant Equipment
208396000
Annuals > 1 > balance Sheet > total Assets
647067000
Annuals > 1 > balance Sheet > payables
77021000
Annuals > 1 > balance Sheet > short Term Debt
65921000
Annuals > 1 > balance Sheet > long Term Debt
291048000
Annuals > 1 > balance Sheet > total Liabilities
566342000
Annuals > 1 > balance Sheet > equity
79772000
Annuals > 1 > balance Sheet > currency_symbol
EUR
Annuals > 1 > cash Flow > net Income
7380000
Annuals > 1 > cash Flow > depreciation
63331000
Annuals > 1 > cash Flow > change In Working Capital
-3770000
Annuals > 1 > cash Flow > cash From Operations
66038000
Annuals > 1 > cash Flow > capital Expenditures
55395000
Annuals > 1 > cash Flow > cash From Investing
-43654000
Annuals > 1 > cash Flow > cash From Financing
-35552000
Annuals > 1 > cash Flow > net Change In Cash
-13090000
Annuals > 1 > cash Flow > currency_symbol
EUR
Annuals > 1 > ratios > PE
-0.12063615465555026
Annuals > 1 > ratios > PB
2.2959691057012486
Annuals > 1 > ratios > ROE
-1.1282154139296996
Annuals > 1 > ratios > ROA
-0.13908915150981274
Annuals > 1 > ratios > FCF
10643000
Annuals > 1 > ratios > Piotroski FScore
2
Annuals > 1 > ratios > fcf Percent
0.020090419156024955
Annuals > 1 > health Score
18
Annuals > 2 > quarter
2023-06-30
Annuals > 2 > income Statement > revenue
508031000
Annuals > 2 > income Statement > cost Of Revenue
174303000
Annuals > 2 > income Statement > gross Profit
333728000
Annuals > 2 > income Statement > operating Expenses
297071000
Annuals > 2 > income Statement > operating Income
36657000
Annuals > 2 > income Statement > interest Expense
16593000
Annuals > 2 > income Statement > pretax Income
22765000
Annuals > 2 > income Statement > net Income
12047000
Annuals > 2 > income Statement > eps
1.517660391772308
Annuals > 2 > income Statement > dividends Per Share
613000
Annuals > 2 > income Statement > shares Outstanding
7937876
Annuals > 2 > income Statement > income Tax Expense
5960000
Annuals > 2 > income Statement > EBITDA
98154000
Annuals > 2 > income Statement > operating Margin
7.215504565666269
Annuals > 2 > income Statement > total Other Income Expense Net
-13892000
Annuals > 2 > income Statement > currency_symbol
EUR
Annuals > 2 > balance Sheet > cash
36706000
Annuals > 2 > balance Sheet > short Term Investments
-10457000
Annuals > 2 > balance Sheet > receivables
96118000
Annuals > 2 > balance Sheet > inventories
60381000
Annuals > 2 > balance Sheet > total Current Assets
196412000
Annuals > 2 > balance Sheet > property Plant Equipment
210200000
Annuals > 2 > balance Sheet > total Assets
657080000
Annuals > 2 > balance Sheet > payables
73059000
Annuals > 2 > balance Sheet > short Term Debt
92281000
Annuals > 2 > balance Sheet > long Term Debt
275342000
Annuals > 2 > balance Sheet > total Liabilities
568989000
Annuals > 2 > balance Sheet > equity
87648000
Annuals > 2 > balance Sheet > currency_symbol
EUR
Annuals > 2 > cash Flow > net Income
12748000
Annuals > 2 > cash Flow > depreciation
58757000
Annuals > 2 > cash Flow > change In Working Capital
10153000
Annuals > 2 > cash Flow > cash From Operations
105680000
Annuals > 2 > cash Flow > capital Expenditures
53634000
Annuals > 2 > cash Flow > cash From Investing
-76249000
Annuals > 2 > cash Flow > cash From Financing
-7887000
Annuals > 2 > cash Flow > net Change In Cash
21506000
Annuals > 2 > cash Flow > currency_symbol
EUR
Annuals > 2 > ratios > PE
1.517660391772308
Annuals > 2 > ratios > PB
2.223380519806499
Annuals > 2 > ratios > ROE
13.744751734209565
Annuals > 2 > ratios > ROA
1.833414500517441
Annuals > 2 > ratios > FCF
52046000
Annuals > 2 > ratios > Piotroski FScore
3
Annuals > 2 > ratios > fcf Percent
0.10244650424875647
Annuals > 2 > health Score
53
Annuals > 3 > quarter
2022-06-30
Annuals > 3 > income Statement > revenue
468300000
Annuals > 3 > income Statement > cost Of Revenue
161500000
Annuals > 3 > income Statement > gross Profit
306800000
Annuals > 3 > income Statement > operating Expenses
275581000
Annuals > 3 > income Statement > operating Income
32544000
Annuals > 3 > income Statement > interest Expense
12779000
Annuals > 3 > income Statement > pretax Income
21015000
Annuals > 3 > income Statement > net Income
13681000
Annuals > 3 > income Statement > eps
1.85544407580888
Annuals > 3 > income Statement > dividends Per Share
2403000
Annuals > 3 > income Statement > shares Outstanding
7373437
Annuals > 3 > income Statement > income Tax Expense
5928000
Annuals > 3 > income Statement > EBITDA
89834000
Annuals > 3 > income Statement > operating Margin
6.949391415759129
Annuals > 3 > income Statement > total Other Income Expense Net
-11528000
Annuals > 3 > income Statement > currency_symbol
EUR
Annuals > 3 > balance Sheet > cash
22133000
Annuals > 3 > balance Sheet > short Term Investments
-152000
Annuals > 3 > balance Sheet > receivables
95898000
Annuals > 3 > balance Sheet > inventories
61479000
Annuals > 3 > balance Sheet > total Current Assets
186642000
Annuals > 3 > balance Sheet > property Plant Equipment
207698000
Annuals > 3 > balance Sheet > total Assets
632552000
Annuals > 3 > balance Sheet > payables
63794000
Annuals > 3 > balance Sheet > short Term Debt
55948000
Annuals > 3 > balance Sheet > long Term Debt
296965000
Annuals > 3 > balance Sheet > total Liabilities
545889000
Annuals > 3 > balance Sheet > equity
84564000
Annuals > 3 > balance Sheet > currency_symbol
EUR
Annuals > 3 > cash Flow > net Income
14326000
Annuals > 3 > cash Flow > depreciation
59419000
Annuals > 3 > cash Flow > change In Working Capital
-28861000
Annuals > 3 > cash Flow > cash From Operations
56857000
Annuals > 3 > cash Flow > capital Expenditures
53271000
Annuals > 3 > cash Flow > cash From Investing
-104452000
Annuals > 3 > cash Flow > cash From Financing
29426000
Annuals > 3 > cash Flow > net Change In Cash
-18077000
Annuals > 3 > cash Flow > currency_symbol
EUR
Annuals > 3 > ratios > PE
1.85544407580888
Annuals > 3 > ratios > PB
2.140602127974079
Annuals > 3 > ratios > ROE
16.17827917317062
Annuals > 3 > ratios > ROA
2.1628261391948804
Annuals > 3 > ratios > FCF
3586000
Annuals > 3 > ratios > Piotroski FScore
4
Annuals > 3 > ratios > fcf Percent
0.0076574845184710656
Annuals > 3 > health Score
47
Valuation > metrics > PE
64.2105
Valuation > metrics > PB
2.507812393944435
Valuation > final Score
50
Valuation > verdict
78.4% Overvalued
Profitability > metrics > ROE
-0.12061221094659791
Profitability > metrics > ROA
-0.031454840610730075
Profitability > metrics > Net Margin
-0.00040342961544347116
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
8.1757056507514
Risk > metrics > Interest Coverage
1.2545098039215685
Risk > final Score
11
Risk > verdict
High
Liquidity > metrics > Current Ratio
2.6622806595374
Liquidity > metrics > Quick Ratio
2.2776852662887066
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
100
Prev Valuations > 1
100
Prev Valuations > 2
80
Prev Profitabilities > 0
3
Prev Profitabilities > 1
5
Prev Profitabilities > 2
0
Prev Risks > 0
12
Prev Risks > 1
11
Prev Risks > 2
12
Prev Liquidities > 0
93
Prev Liquidities > 1
87
Prev Liquidities > 2
88
Updated At
2026-01-20T23:09:26.208Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-03-17
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
AfterMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Bastide Le Confort Médical SA, together with its subsidiaries, engages in the sale and rental of medical equipment in France, the United Kingdom, Belgium, Spain, Canada, the Netherlands, and Italy. It operates in six segments: Respiratory Assistance, Home Care, Healthcare Facilities, Nutrition/Infusion/Diabetes, Stoma Therapy/Urology/Wound Care, and E-commerce. The company offers reclining chairs, lift chairs, and accessories and tables for armchairs; incontinence products, including sample wait, slip absorbent, adult complete change, incontinence diapers, and onesies, anatomical, male urinary, and right-hand protections, incontinence panties and swimsuits, disposable bed pads, support briefs, slips filets, feminine hygiene products, hygiene incontinence, and washable and reusable briefs and panties for urinary incontinence; and mobility products, such as walkers and rollators, walking sticks, electric scooters, and manual and electric wheelchairs. It also provides medical equipment comprising heating products, bathroom medical equipment, medical measuring device, medical pillow and cushion, technical support, electrostimulation and circulatory stimulators, pressotherapy device, pedal exerciser for seniors, seniors' telephone, bedside tables, medicalized room, sleep apnea device, natural food supplement, thermal compresses, pedicure and foot care, comfort shoes, first aid products, and wellness and health. In addition, the company offers professional equipment, which includes consumable for healthcare professionals, hygiene and disinfection, care and dressings, diagnosis and self-checking, and other medical equipment; and rental and services for medical bed, wheelchair, air mattress, patient lift, and verticalizer. It exports its products. The company was incorporated in 1976 and is headquartered in Caissargues, France. Bastide Le Confort Médical SA operates as a subsidiary of Societe d'Investissement Bastide SAS.
Stock Price
€0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2025-06-30)
Rating:
BUY
$
Analyst Picks
Strong Buy
1
Buy
2
Hold
0
Sell
0
Strong Sell
0
(Last Updated 2025-06-30)
Health Score
Price to Earnings Ratio (P/E)
-
Very Low
Low ≥ 50
High ≤ 10
Price to Book Ratio (P/B)
-
High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Bastide Le Confort Médical SA
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
—
Date
—
EPS Actual
—
EPS Estimate
—
EPS Difference
—
Surprise Percent
undefined%
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
€ 0
Cost Of Revenue
€ 0
Gross Profit
€ 0
Operating Expenses
€ 0
Operating Income
€ 0
Interest Expense
€ 0
Pretax Income
€ 0
Net Income
€ 0
Income Tax Expense
€ 0
EBITDA
€ 0
Total Other Income Expense Net
€ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
€ 0
Short Term Investments
€ 0
Receivables
€ 0
Inventories
€ 0
Total Current Assets
€ 0
Property Plant Equipment
€ 0
Total Assets
€ 0
Payables
€ 0
Short Term Debt
€ 0
Long Term Debt
€ 0
Total Liabilities
€ 0
Equity
€ 0
(Last Updated 2025-06-30)
Net Income
€ 0
Depreciation
€ 0
Change In Working Capital
€ 0
Cash From Operations
€ 0
Capital Expenditures
€ 0
Cash From Investing
€ 0
Cash From Financing
€ 0
Net Change In Cash
€ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.